03.16.18
Conffianz added industry veteran Albert Draaijer to its board of directors. With previous executive leadership roles at Nestlé Consumer Health (Proactiv and Cetaphil) and Galderma, he brings decades of experience, insight and a robust network of top talent to help support Conffianz's growing direct- to- consumer and retail business.
While at Nestlé Consumer Health, Draaijer was responsible for starting the consumer division, with household names such as Cetaphil and Proactiv, the latter being acquired by Nestlé after his leadership of the M&A activity and later serving as a managing board member. Prior to Nestle, he led markets and global business units for Galderma, SA, where he was responsible for expanding pharmaceutical brands into international markets, growing total revenues from $400 million to $1.5 billion during his tenure.
While at Nestlé Consumer Health, Draaijer was responsible for starting the consumer division, with household names such as Cetaphil and Proactiv, the latter being acquired by Nestlé after his leadership of the M&A activity and later serving as a managing board member. Prior to Nestle, he led markets and global business units for Galderma, SA, where he was responsible for expanding pharmaceutical brands into international markets, growing total revenues from $400 million to $1.5 billion during his tenure.